Skip to main content
NCBI home page
Gut logoLink to Gut
. 1978 Nov;19(11):1022–1026. doi: 10.1136/gut.19.11.1022

Hepatocellular carcinoma in Great Britain: influence of age, sex, HBsAg status, and aetiology of underlying cirrhosis.

P J Johnson, N Krasner, B Portmann, A L Eddleston, R Williams
PMCID: PMC1412242  PMID: 215496

Abstract

An analysis of 294 patients who died with cirrhosis showed that 24% had developed hepatocellular carcinoma. Haemochromatosis and HBsAg positive chronic active hepatitis were high risk groups (36% and 42% respectively) and the frequency was lowest in primary biliary cirrhosis and HBsAg negative chronic active hepatitis (3% and 11% respectively). Those with hepatocellular carcinoma showed a striking male preponderance (11:1) and further analysis has shown that the proportion developing this tumour in each group was closely related to the proportion of males in that group (r=0.97). Age was the only other significant factor, malignant change occurring more commonly in those over the age of 50 years than those below (30% and 7% respectively, P less than 0.005). The indluence of HBsAg was largely accounted for by the known predisposition of males to carry HBsAg. The group of patients who had developed this tumour without cirrhosis were younger (mean age 39 years) and had a lower male to female ratio of 1.1:1 and the place of contraceptive-related tumour within this group is dicussed.

Full text

PDF
1022

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AGNEW L. R. C., GARDNER W. U. The incidence of spontaneous hepatomas in C3H, C3H (low milk factor), and CBA mice and the effect of estrogen and androgen on the occurrence of these tumors in C3H mice. Cancer Res. 1952 Oct;12(10):757–761. [PubMed] [Google Scholar]
  2. Alpert M. E., Hutt M. S., Wogan G. N., Davidson C. S. Association between aflatoxin content of food and hepatoma frequency in Uganda. Cancer. 1971 Jul;28(1):253–260. doi: 10.1002/1097-0142(197107)28:1<253::aid-cncr2820280151>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  3. Baum J. K., Bookstein J. J., Holtz F., Klein E. W. Possible association between benign hepatomas and oral contraceptives. Lancet. 1973 Oct 27;2(7835):926–929. doi: 10.1016/s0140-6736(73)92594-4. [DOI] [PubMed] [Google Scholar]
  4. Bomford A., Williams R. Long term results of venesection therapy in idiopathic haemochromatosis. Q J Med. 1976 Oct;45(180):611–623. [PubMed] [Google Scholar]
  5. Christopherson W. M., Mays E. T., Barrows G. H. Liver tumors in women on contraceptive steroids. Obstet Gynecol. 1975 Aug;46(2):221–223. [PubMed] [Google Scholar]
  6. Christopherson W. M., Mays E. T. LETTER: Liver tumours and oral contraceptives. Lancet. 1976 May 15;1(7968):1076–1076. doi: 10.1016/s0140-6736(76)92248-0. [DOI] [PubMed] [Google Scholar]
  7. Davidson A. R., Tomlinson S., Calne R. Y., Williams R. The variable course of primary hepatocellular carcinoma. Br J Surg. 1974 May;61(5):349–352. doi: 10.1002/bjs.1800610504. [DOI] [PubMed] [Google Scholar]
  8. Davis M., Portmann B., Searle M., Wright R., Williams R. Histological evidence of carcinoma in a hepatic tumour associated with oral contraceptives. Br Med J. 1975 Nov 29;4(5995):496–498. doi: 10.1136/bmj.4.5995.496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Farrell G. C., Joshua D. E., Uren R. F., Baird P. J., Perkins K. W., Kronenberg H. Androgen-induced hepatoma. Lancet. 1975 Feb 22;1(7904):430–432. doi: 10.1016/s0140-6736(75)91494-4. [DOI] [PubMed] [Google Scholar]
  10. GALL E. A. Primary and metastatic carcinoma of the liver. Relationship to hepatic cirrhosis. Arch Pathol. 1960 Aug;70:226–232. [PubMed] [Google Scholar]
  11. Johnson F. L., Lerner K. G., Siegel M., Feagler J. R., Majerus P. W., Hartmann J. R., Thomas E. D. Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma. Lancet. 1972 Dec 16;2(7790):1273–1276. doi: 10.1016/s0140-6736(72)92649-9. [DOI] [PubMed] [Google Scholar]
  12. Lee F. I. Cirrhosis and hepatoma in alcoholics. Gut. 1966 Feb;7(1):77–85. doi: 10.1136/gut.7.1.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. MacSween R. N. A clinicopathological review of 100 cases of primary malignant tumours of the liver. J Clin Pathol. 1974 Aug;27(8):669–682. doi: 10.1136/jcp.27.8.669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. PARKER R. G. The incidence of primary hepatic carcinoma in cirrhosis. Proc R Soc Med. 1957 Mar;50(3):145–147. [PMC free article] [PubMed] [Google Scholar]
  15. Powell L. W., Mortimer R., Harris O. D. Cirrhosis of the liver. A comparative study of the four major aetiological groups. Med J Aust. 1971 May 1;1(18):941–950. [PubMed] [Google Scholar]
  16. Reuber M. D. Influence of hormones on N-2-fluorenyldiacetamide-induced hyperplastic hepatic nodules in rats. J Natl Cancer Inst. 1969 Aug;43(2):445–452. [PubMed] [Google Scholar]
  17. SHERLOCK S. Primary billiary cirrhosis (chronic intrahepatic obstructive jaundice). Gastroenterology. 1959 Nov;37:574–586. [PubMed] [Google Scholar]
  18. Stone W. D., Islam N. R., Paton A. The natural history of cirrhosis. Experience with an unselected group of patients. Q J Med. 1968 Jan;37(145):119–132. [PubMed] [Google Scholar]
  19. Tong M. J., Sun S. C., Schaeffer B. T., Chang N. K., Lo K. J., Peters R. L. Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan. Ann Intern Med. 1971 Nov;75(5):687–691. doi: 10.7326/0003-4819-75-5-687. [DOI] [PubMed] [Google Scholar]
  20. Vogel C. L., Anthony P. P., Mody N., Barker L. F. Hepatitis-associated antigen in Ugandan patients with hepatocellular carcinoma. Lancet. 1970 Sep 26;2(7674):621–624. doi: 10.1016/s0140-6736(70)91396-6. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES